BR0001606A - Composições de hormÈnio de crescimento e de hormÈnio de liberação de hormÈnio de crescimento - Google Patents
Composições de hormÈnio de crescimento e de hormÈnio de liberação de hormÈnio de crescimentoInfo
- Publication number
- BR0001606A BR0001606A BR0001606-3A BR0001606A BR0001606A BR 0001606 A BR0001606 A BR 0001606A BR 0001606 A BR0001606 A BR 0001606A BR 0001606 A BR0001606 A BR 0001606A
- Authority
- BR
- Brazil
- Prior art keywords
- growth hormone
- hormone
- compositions
- growth
- releasing
- Prior art date
Links
- 102000018997 Growth Hormone Human genes 0.000 title abstract 7
- 108010051696 Growth Hormone Proteins 0.000 title abstract 7
- 239000000122 growth hormone Substances 0.000 title abstract 7
- 102000038461 Growth Hormone-Releasing Hormone Human genes 0.000 title abstract 4
- 239000000095 Growth Hormone-Releasing Hormone Substances 0.000 title abstract 4
- 101710142969 Somatoliberin Proteins 0.000 title abstract 4
- 239000000203 mixture Substances 0.000 title abstract 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 241001465754 Metazoa Species 0.000 abstract 1
- 230000007812 deficiency Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 239000005556 hormone Substances 0.000 abstract 1
- 229940088597 hormone Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/61—Growth hormone [GH], i.e. somatotropin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/60—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Endocrinology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Patente de Invenção: <B>"COMPOSIçõES DE HORMÈNIO DE CRESCIMENTO E DE HORMÈNIO DE LIBERAçãO DE HORMÈNIO DE CRESCIMENTO"<D>. A presente invenção refere-se a métodos e composições do hormónio de crescimento e/ou hormónio de liberação de hormónio de crescimento que promovem a liberação e a elevação do hormónio de crescimento quando administrados a animais. A presente invenção está ainda refere-se a métodos e composições do hormónio de crescimento e/ou hormónio de liberação de hormónio de crescimento para o tratamento de doenças ou desordens resultantes de deficiências relacionadas ao hormónio de crescimento. A invenção fornece também métodos para produzir novas variantes do hormónio de liberação de hormónio de crescimento e os seus usos.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12883099P | 1999-04-12 | 1999-04-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0001606A true BR0001606A (pt) | 2001-04-24 |
Family
ID=22437190
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0001606-3A BR0001606A (pt) | 1999-04-12 | 2000-04-12 | Composições de hormÈnio de crescimento e de hormÈnio de liberação de hormÈnio de crescimento |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1052286A3 (pt) |
JP (3) | JP2000350590A (pt) |
BR (1) | BR0001606A (pt) |
CA (1) | CA2303702A1 (pt) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6759393B1 (en) | 1999-04-12 | 2004-07-06 | Pfizer Inc. | Growth hormone and growth hormone releasing hormone compositions |
EP1205551A1 (en) * | 2000-11-09 | 2002-05-15 | Pfizer Products Inc. | Growth hormone and growth hormone releasing hormone compositions |
AR037778A1 (es) * | 2001-12-11 | 2004-12-01 | Advisys Inc | Suplementacion mediada por plasmido para el tratamiento de sujetos cronicamente enfermos |
CA2524229C (en) | 2003-05-01 | 2014-04-08 | Merial Limited | Canine ghrh gene, polypeptides and methods of use |
US7468273B2 (en) * | 2003-05-01 | 2008-12-23 | Meial Limited | Canine GHRH gene, polypeptides and methods of use |
MX2007000893A (es) * | 2004-07-23 | 2007-04-18 | Advisys Inc | La hormona liberadora de hormona de crecimiento mejora la respuesta inmune inducida por la vacunacion. |
DK1881845T3 (da) | 2005-04-25 | 2010-06-07 | Merial Ltd | Nipah-virusvacciner |
US7771995B2 (en) | 2005-11-14 | 2010-08-10 | Merial Limited | Plasmid encoding human BMP-7 |
CA2629522A1 (en) | 2005-11-14 | 2007-05-18 | Merial Limited | Gene therapy for renal failure |
WO2012145577A1 (en) | 2011-04-20 | 2012-10-26 | Merial Limited | Adjuvanted rabies vaccine with improved viscosity profile |
WO2013138776A1 (en) | 2012-03-16 | 2013-09-19 | Merial Limited | Novel methods for providing long-term protective immunity against rabies in animals, based upon administration of replication-deficient flavivirus expressing rabies g |
CN102978202A (zh) * | 2012-10-10 | 2013-03-20 | 中国农业科学院北京畜牧兽医研究所 | 一种肌肉特异表达猪igf1基因的过表达载体 |
CN113929761B (zh) * | 2020-03-18 | 2024-02-20 | 深圳纳福生物医药有限公司 | 新型生长激素释放激素类似肽改构和二聚体化制备及其应用 |
CN114891690B (zh) * | 2022-06-08 | 2023-09-08 | 山东仙普爱瑞科技股份有限公司 | 一种具有促生长性能的复合菌剂及其应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1234977B (it) * | 1985-03-22 | 1992-06-09 | Serono Ist Farm | Espressione in e. coli polipeptidi ibridi contenenti la sequenza del fattore di rilascio dell'ormone della crescita |
SK60893A3 (en) * | 1990-12-13 | 1993-10-06 | Upjohn Co | Fusion polypeptides |
CA2158782C (en) * | 1994-09-23 | 2010-01-12 | Pierrette Gaudreau | Marker for growth hormone-releasing factor receptors |
BRPI9608799B8 (pt) * | 1995-05-26 | 2019-11-05 | Theratechnologies Inc | análogo pró-grf -corpo graxo quimérico com aumentada potência biológica, e, formulação farmacêutica. |
WO1999005300A2 (en) * | 1997-07-24 | 1999-02-04 | Valentis, Inc. | Ghrh expression system and methods of use |
-
2000
- 2000-04-12 CA CA002303702A patent/CA2303702A1/en not_active Abandoned
- 2000-04-12 EP EP00302790A patent/EP1052286A3/en not_active Withdrawn
- 2000-04-12 BR BR0001606-3A patent/BR0001606A/pt not_active IP Right Cessation
- 2000-04-12 JP JP2000111120A patent/JP2000350590A/ja active Pending
-
2002
- 2002-01-17 JP JP2002008803A patent/JP2002302449A/ja active Pending
- 2002-06-12 JP JP2002171697A patent/JP2003052390A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP1052286A2 (en) | 2000-11-15 |
EP1052286A3 (en) | 2001-07-25 |
JP2002302449A (ja) | 2002-10-18 |
JP2003052390A (ja) | 2003-02-25 |
CA2303702A1 (en) | 2000-10-12 |
JP2000350590A (ja) | 2000-12-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0001606A (pt) | Composições de hormÈnio de crescimento e de hormÈnio de liberação de hormÈnio de crescimento | |
BR9715022A (pt) | Método para tratar de doenças prostáticas usando formulações de vitamina d por liberação sistemática e/ou prolongada | |
BR0015284A (pt) | Formulações de hidrocodona de liberação controlada | |
EA199900964A1 (ru) | Соли сертралина и лекарственные формы с длительным высвобождением сертралина | |
BR0014996A (pt) | Método para prevenir ou melhorar a dor de um ferimento fechado cirurgicamente em um indivìduo, e, emplastro | |
ATE237330T1 (de) | Verabreichung von nikotin im dickdarm zur behandlung von entzündlicher eingeweidenerkrankung | |
BR0317888A (pt) | Cristais do hormÈnio do crescimento humano e processos para preparação dos mesmos | |
ATE118170T1 (de) | Pharmazeutische zubereitung mit verzögerter freisetzung zur behandlung periodontaler erkrankungen. | |
BR0111916A (pt) | Métodos e composição para vacinação oral | |
ZA95741B (en) | Therapeutic agents | |
HUP9902553A2 (hu) | Mikrocseppekből álló propofol készítmények | |
BR0008323A (pt) | Derivado de gabapentina para a prevenção e o tratamento de dor visceral | |
PT918517E (pt) | Composicao de microrganismos contendo acidos gordos omega-3 util como agente profilactico ou terapeutico contra a cocidiose dos animais | |
CA2029047A1 (en) | Sustained release compositions for treating periodontal disease | |
US4469702A (en) | Analgesic composition and use thereof to ameliorate deep and intractable pain | |
ATE88633T1 (de) | Verwendung von bestimmten calcium-citrate-malaten zur herstellung einer pharmazeutischen zubereitung fuer die behandlung von osteoporose. | |
BR9913337A (pt) | Derivados tan-1057 | |
BR0014198A (pt) | Processo para o gerenciamento terapêutico da proliferação extra-uterina de tecido endometrial, dor pélvica crÈnica e obstrução da tuba de falópio | |
ATE373482T1 (de) | Pharmazeutische zusammensetzung zur lokalen behandlung von hauterkrankungen und hautwunden | |
BR0213634A (pt) | Sistema de liberação de droga com ação retardada para um agente antiespasmódico | |
Greenstein | Studies on a new, peerless contraceptive agent: a preliminary final report | |
BR0114339A (pt) | Composições farmaceuticamente aceitáveis contendo epinastina e pseudoefedrina | |
Sandyk | Yawning and stretching-a behavioral syndrome associated with transcranial application of electromagnetic fields in multiple sclerosis | |
Husain | Homeopathy in Practice: Clinical Insights into Homeopathy & Remedies | |
ATE401871T1 (de) | Methanal - injektion zur behandlung epidemischer tierkrankheiten |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application fees: dismissal - article 86 of industrial property law |
Free format text: REFERENTE A 4A, 5A E 7A ANUIDADES |
|
B08K | Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87) |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1913 DE 04/09/2007. |